anti-inflammatory program (MuriGen)

N/A

Report date: 2025/03/17 09:45:57
NME

Base Information

Drug Nameanti-inflammatory program (MuriGen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMuriGen Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMuriGen Therapeutics
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A